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Electrospray ionization (ESI) and collisionally induced dissociation (CID) mass spectra were
obtained for five tetracyclines and the corresponding compounds in which the labile
hydrogens were replaced by deuterium by either gas phase or liquid phase exchange. The
number of labile hydrogens, x, could easily be determined from a comparison of ESI
spectra obtained with N2 and with ND3 as the nebulizer gas. CID mass spectra were
obtained for [M  H] and [M  H] ions and the exchanged analogs, [M(Dx)  D]
 and
[M(Dx)  D]
, and produced by ESI using a Sciex API-IIIplus and a Finnigan LCQ ion trap
mass spectrometer. Compositions of product ions and mechanisms of decomposition were
determined by comparison of the MSN spectra of the un-deuterated and deuterated
species. Protonated tetracyclines dissociate initially by loss of H2O (D2O) and NH3 (ND3)
if there is a tertiary OH at C-6. The loss of H2O (D2O) is the lower energy process.
Tetracyclines without the tertiary OH at C-6 lose only NH3 (ND3) initially. MS
N
experiments showed easily understandable losses of HDO, HN(CH3)2, CH3  N¢CH2, and
CO from fragment ions. The major fragment ions do not come from cleavage reactions of
the species protonated at the most basic site. Deprotonated tetracyclines had similar CID
spectra, with less fragmentation than those observed for the protonated tetracyclines. The
lowest energy decomposition paths for the deprotonated tetracyclines are the competitive
loss of NH3 (ND3) or HNCO (DNCO). Product ions appear to be formed by charge remote
decompositions of species de-protonated at the C-10 phenol. (J Am Soc Mass Spectrom
2002, 13, 543–557) © 2002 American Society for Mass Spectrometry
Mass spectrometry has long been regarded as animportant analytical tool in drug metabolism,pharmacokinetics, and biochemical toxicol-
ogy. However, with the commercial availability of new
ionization methods, such as atmospheric pressure ion-
ization (API) and ESI, and the combination of liquid
chromatography-massspectrometry(LC-MS),massspec-
trometry is now a truly indispensable technique in
pharmaceutical science. LC-MS systems equipped with
electrospray, ionspray, or heated nebulizer interfaces
have been utilized extensively in metabolic studies of
foreign compounds because of their very high sensitiv-
ity, their compatibility with reverse-phase chromatog-
raphy, and their applicability to structural elucidation
of polar and thermally labile drug conjugates.
The most widely used approach for obtaining struc-
tural information on compounds analyzed by the soft
ionization methods mentioned above has been through
collisionally induced decompositions (CID) of proton-
ated molecules, [M  H], or deprotonated molecules,
[M  H]. CID studies are employed in structural
characterization of compounds because the collision
process is an effective means of introducing sufficient
internal energy into the protonated or deprotonated
molecules for extensive fragmentation. Tandem mass
spectrometry also allows an unambiguous assignment
of reactant/product sequences free of interferences that
may be present in complex biological fluids or reaction
mixtures.
The determination of the number of replaceable
hydrogens, such as OH, COOH, NH, or SH, by simple
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exchange of the sample in the presence of heavy water,
D2O, is widely used in mass spectrometry. Although
the incorporation of deuterium can be effectively car-
ried out by a variety of preparative liquid and gas
chromatographic procedures, the direct combination of
LC with MS obviates the necessity of isolation of
individual components. In addition, the coupling per-
mits direct comparison of mass spectra of labeled
compounds of a mixture with spectra of unlabeled
components obtained in a conventional fashion from a
separate chromatographic analysis, but under essen-
tially identical mass spectrometric conditions.
The chemical incorporation of deuterium followed
by ionization has played a major role in the structural
characterization of molecules, in gaining information on
the mechanisms of chemical or biological reactions, and
in the interpretation of mass spectra [1–7]. Many ion-
ization methods have been used: Electron ionization
(EI) [1], chemical ionization (CI) [8–10], fast atom bom-
bardment (FAB) [11–13], thermospray [14, 15], particle
beam [15], and electrospray ionization (ESI) [3, 16–25].
The exchange of hydrogen by deuterium has been used
extensively in the study of gas phase ion molecule
reactions [26]. Isotopic exchange reactions in CI systems
are normally carried out in solution before the sample is
introduced into the mass spectrometer but exchange
can also occur in the ion source of the mass spectrom-
eter [26, 27].
Hemling and co-workers developed a simple
method for gas phase hydrogen/deuterium exchange
that required only minor changes in the plumbing of
a Sciex API-IIIplus ion spray source. Extensive ex-
change of active hydrogens was achieved by replac-
ing either all or part of the nebulizer or curtain gas
with a deuterated exchange agent like ND3. The
authors reported gas phase H/D exchange of ions
produced by ESI that compared favorably with de-
sorption chemical ionization and FAB exchange
methods [28].
The tetracyclines are an important family of antibi-
otics. Structural modifications of tetracyclines play crit-
ical roles in their functions, both chemical modification
and xenobiotic alteration. Nine closely related com-
pounds—tetracycline, rolitetracycline, oxytetracycline,
chlortetracycline, demeclocycline, meclocycline, metha-
cycline, doxycycline, and minocycline—are widely used
in human and veterinary medicine. The tetracyclines
have been monitored by high pressure liquid chroma-
tography (HPLC) with ultraviolet or fluorescence detec-
tion [29], thin layer chromatography and LC/FAB/MS
[30, 31], LC/particle beam/MS [32], and ESI/MS [33–
40]. Mass spectrometric techniques for the analysis of
tetracycline antibiotics in foods have been reviewed
[41]. Some CID spectra of tetracyclines have been re-
ported previously [42, 43].
Figure 1. Structures of tetracyclines
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The present study was undertaken to determine
structures and mechanisms of formation of principal
fragment ions in the ESI mass spectra of five tetracy-
clines. Hydrogen/deuterium exchange and multiple
stage mass spectrometry in positive and negative ion-
ization modes were utilized to determine fragmentation
processes. Knowledge of fragmentation mechanisms for
CID spectra of [M  H] and [M  H] ions for
tetracyclines can aid in the characterization of metabo-
lites of the tetracyclines and related compounds.
Experimental
Chemicals and Materials
Five tetracyclines, shown in Figure 1 with the number-
ing system for tetracycline, were purchased from Sigma
Figure 2. CID product ion spectra of [M  H] ions of Tetracyclines at low collision energy (CE) of
5 eV using a Sciex API IIIplus quadrupole mass spectrometer.
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Chemical Co. (St. Louis, MO). Methanol and deionized
water (HPLC grade) were obtained from J. T. Baker
(Phillipsburg, NJ). Glacial acetic acid and ammonium
hydroxide (HPLC grade) were obtained from Fisher (Fair
Lawn, NJ). Deuterated ammonia (99% ND3) was ob-
tained from Cambridge Isotopes Laboratory (Andover,
MA). The other deuterated compounds (99% D) were
obtained from Aldrich Chemical Co. (Milwaukee, WI).
Hydrogen/Deuterium Exchange
Both gas phase and solution phase H/D exchange were
used to determine fragmentation pathways of [M 
H] and [M  H] ions of the tetracyclines. A modifi-
cation was made to the Sciex API-IIIplus electrospray
source to allow gas phase H/D exchange in the nebu-
lization region, as described by Hemling et al. [28]. This
modification involved the addition of a valve prior to
the nebulizer for rapid switching from the N2 normally
used for nebulization to ND3 during loop injection
analysis of a sample. Normal spectra and H/D exchanged
spectra for a single injection were obtained by averaging
several (5–10) spectra with N2 as the nebulizer gas and
then switching to ND3 for several scans and then switch-
ing to N2 for subsequent experiments. Both partially
exchanged and fully exchanged species were observed.
However, for these compounds it was easy to determine
the number of exchangeable hydrogens.
Solution phase H/D exchange was achieved by
dissolving samples in D2O/CH3OD with 1%
CD3COOD for positive ion spectra and 50 mM ND4OD
for negative ion spectra.
Sample Preparation and Introduction
Each tetracycline was dissolved in H2O/CH3OH (1/1
by volume) to make a 20 g/mL solution with 1%
CH3COOH or 50 mM NH4OH for positive or negative
ion spectra, respectively. Recent work from this labora-
tory showed that 1% CH3COOH or 50 mM NH4OH
significantly increased the sensitivities of tetracyclines
and antiviral agents in the positive or negative ioniza-
tion mode, respectively [40, 44]. For solution phase
H/D exchange, each tetracycline was dissolved in
D2O/CH3OD (1/1 by volume) to make a make a 20
g/mL solution with 1% CD3COOD for positive ion
spectra or 50 mM ND4OD for negative ion spectra.
Samples were infused into the electrospray interface
using a Harvard syringe pump (South Natick, MA) at a
flow rate of 2 L/min.
Mass Spectrometry
Mass spectral analyses were performed with a Sciex
API-IIIplus triple quadrupole mass spectrometer with a
mass range to 2400 D (Thornhill, Ontario, Canada). The
mass spectrometer was equipped with an ion spray
interface with a nebulizer gas pressure (N2) of 60 psi.
The nitrogen curtain gas was adjusted to a flow rate of
1.2 L/min. Positive or negative ions formed at atmo-
spheric pressure were sampled into the quadrupole
Figure 3. (a) Intensities of fragment product ions from the
reaction of protonated oxytetracycline with argon (Ar) in the
collision chamber of a triplequadrupole mass spectrometer as a
function of collision energy (Ii is the ion intensity of a fragment ion
and Ii is the sum of all fragment ions). (b) Ratio of the fragment ion
(m/z 443) to the fragment ion (m/z 444) vs collision energy from the
reaction of protonated oxytetracycline with argon (Ar).
Figure 4. Ratio of the fragment ion (m/z 440) to the fragment ion
(m/z 441) vs collision energy from the reaction of protonated
minocycline with argon (Ar).
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mass filter via a 0.0045 in diameter aperture. CID
studies were performed with Ar at a thickness of 2 
1015 atoms/cm2 with collision energies of 5–25 eV.
Collisions occurred in Q2. Unit mass resolution was
established with a 2 ms dwell time and the signal was
averaged over 10 scans.
An ion trap, Finnigan LCQ (Finnigan MAT, San Jose,
CA), was used for experiments involving multiple
stages of decomposition, MSN, at a spray voltage of
3.5 keV with a current of 2 amp. The capillary was
maintained at 200 °C with an offset voltage of 5 V. CID
spectra are the average of 5–15 scans, depending on the
relative abundance of the precursor ions. The mass
width for isolation prior to the CID experiments was 2
Da. The relative collision energy was set at 10–25%
(arbitrary units). In these experiments the protonated or
deprotonated tetracycline was subjected to CID to pro-
duce a first set of fragment ions, MS/MS or MS2.
Subsequently one of the fragment ions from [M  H]
or [M  H] was isolated and decomposed to give the
next set of fragment ions, MS3, and the process was
continued.
Figure 5. Positive ion ESI mass spectra of oxytetracycline (MW  460): (a) total ion curent (TIC)
showing both [M  H] and [M(d8)  D] in a single experiment (b) CID product ion spectrum of
[M  H] at m/z 461 at a collision energy of 25 eV (c) CID porduct ion spectrum of the fully
exchanged [M(d8)  D] at m/z 470 at a collision energy of 25 eV. Deuteration was achieved by
nebulizer ND3 gas phase H/D exchange on a Sciex API-III
 triple quadrupole mass spectrometer.
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Results and Discussion
Positive Ions
The CID spectra of [M  H] ions of the tetracyclines
obtained at collision energy of 25 eV (lab energy, 2 eV
center of mass energy) contain many fragment ions that
can be used for structure confirmation. However, the
spectra are much simpler at lower collision energies.
The low energy (5 eV) CID mass spectra of five proton-
ated tetracyclines are shown in Figure 2. The spectra of
methacycline and minocycline contain only one product
ion: The loss of NH3 from [M  H]
. The low energy
CID spectra of the other three compounds (tetracycline,
chlortetracycline, and oxytetracycline) are similar and
contain [M  H  H2O]
, [M  H  NH3]
, and [M 
H  H2O  NH3]
 ions. As was noted previously, the
protonated tetracyclines that fragment by loss of water
have structures with a tertiary OH at C-6 [42, 43].
Figure 3 shows the effects of collision energy on the
lowest energy CID products from [M  H] ions of
oxytetracycline. Figure 3a shows a rapid decrease in
relative abundance of [M  H] at m/z 461, maxima in
the relative abundances of [M  H  H2O]
 at m/z 443
and [M  H  NH3]
 at m/z 444, and a rapid increase
in the relative abundance of [MHH2ONH3]
 at
m/z 426 with increasing energy. The maxima with
increasing collision energy in the plots of the relative
abundance of the primary decomposition products at
Scheme 1. Proposed reactions and CID fragmentation pathways mechanisms of protonated oxytet-
racycline and its fragment ions determined from both H/D exchange patterns and ion trap MSN
experiments assuming a proton transfer to the C-6 hydroxyl group. Numbers in parentheses refer to
deuterated fragment ions.
Figure 6. Positive ion ESI mass spectra of oxytetracycline (MW  460) and its fragment ions: MS4 of
fragment ion at m/z 426 (top) and its corresponding deuterated fragment ion at m/z 430 (bottom).
Deuteration was achieved by solution phase H/D exchange method. MS2 and MSN experiments were
performed on a Finnigan-MAT LCQ ion trap mass spectrometry.
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m/z 443 and 444 (Figure 3a) indicate that these ions
decompose to give the ions at m/z 426.
Figure 3b shows the decrease with increasing
collision energy of the ratio of product ions, Ii(443)/
Ii(444)  Ii(M  H  H2O)
/Ii(M  H  NH3)
.
These results show that the loss of water from [M 
H] is the dominant process (a factor of 2) at the
lowest collision energy and presumably corresponds
to the lowest energy decomposition process.
Plots similar to Figures 3a and b were obtained with
[M  H] ions from tetracycline, Ii(427)/Ii(428) Ii(M 
H  H2O)
/Ii(M  H  NH3)
  3.1 @ 5 eV, and from
chlorotetracycline, Ii(461)/Ii(462)Ii(M  H H 2O)
/
Ii(M  H  NH3)
  0.3 @ 5 eV. Subsequent decomposi-
tion reactions observed with these two compounds as
well: [MHH2O]
 ions lost NH3 and [MHNH3]

ions lost H2O to give abundant [M  H  H2O  NH3]

ions for tetracycline and for chlortetracycline.
These data indicate competing parallel decomposi-
tion reactions for these three protonated tetracyclines:
[M H]
m
n
[M H H2O]

[M H NH3]

n
m [M H H2O NH3]

Figure 4 shows a plot of data from similar experiments
with minocycline: An increase with increasing collision
energy for the ratio, Ii(440)/Ii(441)Ii(M  H  H2O)
/
Ii(M  H  NH3)
. Only a very small water loss is
observed. A similar plot is observed for the collision
energy dependence of products of MH ions from metha-
cycline. The ratio of product ions can be extrapolated to
zero at zero collision energy; hence, for these two tetracy-
clines (without a tertiary OH at C-6), the lowest energy
CID process is the loss of NH3 from MH
.
MS/MS experiments with an ion trap show
[M  H  H2O]
 at m/z 443 as essentially the only
decomposition product from [M  H] at m/z 461
from oxytetracycline: Ii(444)/Ii(443)  0.05. Under
comparable collision conditions, [M(D8)  D]
 at m/z
470 from oxytetracycline that has undergone liquid
phase H/D exchange decomposes almost exclusively
to [M(D8)  D  D2O]
 at m/z 450: Ii(451)/Ii(450) 
0.1. There is essentially no loss of HDO from OD with
H bonded to C-5a via charge remote fragmentation of
N-protonated ions [45]. The rigid structure of the four
rings of the tetracyclines indicate that loss of D2O
from the OD group at C-6 and any other OD group is
very unlikely.
Loss of water from a species protonated on the
hydroxyl group at C-6 is a reasonable process. How-
ever, this hydroxyl group should not be the most basic
site of the molecule that one would expect to be
protonated in [M  H] ions produced by ESI. Proton
affinities or basicities of complex molecules like the
tetracyclines are not known. However, one can estimate
the gas phase basicity (GB) of a site from gas phase
basicities of model compounds: The higher GB, the
more basic the site and the greater the equilibrium
population of species protonated at that site [46].
The basicity of the dimethylamino group at C-4
Figure 7. Positive ion ESI mass spectra of oxytetracycline (MW  460) and its fragment ions: MS5 of
fragment ion at m/z 408 (top) and its corresponding deuterated fragment ion at m/z 411 (bottom).
Deuteration was achieved by solution phase H/D exchange method. MS2 and MSN experiments were
performed on a Finnigan-MAT LCQ ion trap mass spectrometry.
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Scheme 2. Proposed CID fragmentation pathways mechanisms of the fragment ion at m/z  426 from
protonated Oxytetracycline determined from both H/D exchange patterns and ion trap MSN
experiments. Numbers in parentheses refer to deuterated fragment ions.
Scheme 3. Proposed CID fragmentation pathways mechanisms of the fragment ion at m/z  426 from
protonated oxytetracycline determined from both H/D exchange patterns and ion trap MSN
experiments. Numbers in parentheses refer to deuterated fragment ions.
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should be slightly larger than GB{s-C4H9N(CH3)2} 
945 kJ/mol. The basicity of the amide group at C-2
should be similar to GB{C2H5CONH2}  845 kJ/mol or
GB{CH2¢CHCONH2}  840 kJ/mol. The basicities of
the hydroxyl groups should be similar to and perhaps
slightly larger than the basicities of s-C4H9OH at 785
kJ/mol and t-C4H9OH at 772 kJ/mol. The basicity of the
phenolic OH at C-10 should be slightly larger than
GB{phenol} 786 kJ/mol. The basicities of the carbonyl
groups at C-1 and C-11 should be similar to GB{3-hexen-
2-one}  834 kJ/mol. All of these data are at 298 K.
The ratio of equilibrium concentrations of species
protonated at two sites should be given approximately
by exp(GB/RT), where GB is the difference in gas
phase basicities of the two sites, R is the gas constant,
and T is the temperature. Then the ratio of hydroxyl-
Table 1. Principal dissociation products of protonated
tetracyclines
Product Ion m/z
Deuterated
product ion
Deuterated
m/z
Tetracycline (MW  444, [M  H]  445, [M(d7)  D]  453)
445 - H2O 427 453 - D2O 433
427 - NH3 410 433 - ND3 413
410 - H2O 392 433 - HDO 394
392 - CO 364 394 - CO 366
392 - CH3 377 394 - CH3 379
392 - H3C™N¢CH2 349 394 - H3C™NCH2 351
349 - CO 321 351 - CO 323
410 - (H3C)2  NH 365 413 - (H3C)2  ND 367
365 - CO 337 367 - CO 339
410 - CO 382 413 - CO 385
445 - NH3  274 154 453 - ND3  274 155
154 - CO 126 155 - CO 127
126 - CO 98 127 - CO 99
126 - C3O2 58 127 - C3O2 59
Oxytetracycline (MW  460, [M  H]  461, [M(d8)  D] 
470)
461 - H2O 443 470 - D2O 450
443 - NH3 426 450 - ND3 430
426 - H2O 408 430 - HDO 411
408 - CO 380 411 - CO 383
380 - H3C™N¢CH2 337 383 - H3C™N¢CH2 340
408 - H3C™N¢CH2 365 411 - H3C™N¢CH2 368
365 - CH3 350 368 - CH3 353
350 - CO 322 353 - CO 325
322 - CO 294 325 - CO 297
426 - (H3C)2™NH 381 430 - (H3C)2™ND 384
381 - CO 353 384 - CO 356
353 - H2O 335 356 - HDO 337
381 - H2O 363 384 - HDO 365
363 - CO 335 365 - CO 337
335 - CO 307 337 - CO 309
426 - 226  H 201 430 - 229  D 203
461 - NH3™218 226 470 - ND3  221 229
226 - CO 198 229 - CO 201
226 - H2O 208 229 - D2O 209
208 - CO 180 209 - CO 181
180 - CO 152 181 - CO 153
226 - 72 154 229 - 74 155
154 - CO 126 155 - CO 127
126 - CO 98 127 - CO 99
126 - C3O2 58 127 - C3O2 59
Chlorotetracycline (MW 478, [MH]  479, [M(d7)D] 487)
479 - H2O 461 487 - D2O 467
461 - NH3 444 467 - ND3 447
444 - H2O 426 447 - HDO 428
426 - CO 398 428 - CO 400
426 - H3C™N¢CH2 383 428 - H3C™N¢CH2 385
383 - CO 355 385 - CO 357
426 - CH3 411 428 - CH3 413
444 - CO 416 447 - CO 419
444 - (H3C)2  NH 399 447 - (H3C)2  ND 401
399 - CO 371 401 - CO 373
399 - H2O 381 401 - HDO 382
479 - NH3  308 154 487 - ND3  312 155
154 - CO 126 155 - CO 127
126 - CO 98 127 - CO 99
126 - C3O2 58 127 - C3O2 59
minocycline (MW  457, [M  H]  458, [M(d6)  D]  465)
458 - NH3 441 465 - ND3 445
(continued)
Table 1. (continued)
Product Ion m/z
Deuterated
product ion
Deuterated
m/z
441 - H2O 423 445-D2O 425
423 - CO 395 425- CO 397
395 - H3C™N¢CH2 352 397 - H3C™N¢CH2 354
395 - CO 367 397 - CO 369
395 - CH3 380 397 - CH3 382
380 - CH3 365 382 - CH3 367
423 - CH3 408 425 - CH3 410
408 - CO 380 410 - CO 382
408 - H3C™N¢CH2 365 410 - H3C™N¢CH2 367
365 - CO 337 367 - CO 339
337 - CO 309 339 - CO 311
337 - CH3 322 339 - CH3 324
337 - C4H6 283 339 - C4H6 285
458 - NH3  287 154 465 - ND3  290 155
154 - CO 126 155 - CO 127
126 - CO 98 127 - CO 99
126 - C3O2 58 127 - C3O2 59
methacycline (MW  442, [M  H]  443, [M(d7)  D]  451)
443 - NH3 426 451 - ND3 431
426 - CO 398 431 - CO 403
426 - (H3C)2  NH 381 431 - (H3C)2  ND 385
381 - CO 353 385 - CO 357
353 - CO 325 357 - CO 329
381 - H2O 363 385 - HDO 366
363 - CO 335 366 - CO 338
335 - CO 301 338 - CO 310
307 - CO 279 310 - CO 282
335 - H2O 317 338 - HDO 319
426 - H2O 408 431 - HDO 412
408 - H2O 390 412 - HDO 393
408 - H3C™N¢CH2 365 412 - H3C™N¢CH2 369
408 - CO 380 412 - CO 384
380 - H3C™N¢CH2 337 384 - H3C™N¢CH2 341
426 - 226  H 201 431 - 229  D 204
426 - 200 226 431 - 202 229
226 - CO 198 229 - CO 201
226 - H2O 208 229 - D2O 209
208 - CO 180 209 - CO 181
180 - CO 152 181 - CO 153
226 - 72 154 229 - 74 155
154 - CO 126 155 - CO 127
126 - CO 98 127 - CO 99
126 - C3O2 58 127 - C3O2 59
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protonated to dimethylamino-protonated species is
vanishingly small: Approximately exp(177*103/RT)
1031 at 298 K. Although these numbers are not accu-
rate, any reasonable estimate of the basicities of the sites
in the tetracyclines indicates negligible equilibrium
concentrations of species protonated at C-6.
The basicity of the amide site in the tetracyclines
should be increased significantly by intramolecular
solvation ofNH3
 with the hydroxyl group at C-3. The
free energy of solvation of NH4
 with H2O is 50
kJ/mol and a similar value of 50 kJ/mol is reported
for the free energy of solvation of CH3NH3
 with
CH3OH [47]. Including the solvation energy, one would
estimate that the GB(dimethylamino group) GB
(amide)50 kJ/mol. Consequently, one would estimate
that the ratio of amide-protonated to dimethylamino-
protonated species would be 109 at 298 K. Although
this value is much larger than the ratio of hydroxyl-
Figure 8. Negative ion ESI mass spectra of minocycline (MW  457): (a) total ion current (TIC)
showing both [M  H] and [M(d6)-D] in a single experiment (b) CID product ion spectrum of [M
 H] at m/z 456 at a collision energy of 20 eV (c) CID product ion spectrum of the fully exchanged
[M(d6)-D] at m/z 461 at a collision energy of20 eV. Deuteration was achieved by nebulizer ND3 gas
phase H/D exchange on a Sciex API-III triple quadrupole mass spectrometer.
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protonated to dimethylamino-protonated species, it is
still a very small number and one would estimate that
the [M  H] ions would be almost exclusively dim-
ethylamino-protonated.
One may also estimate the thermochemistry for the
cleavage reactions from data for simple model com-
pounds. Protonation at the dimethylamino group fol-
lowed by loss of dimethylamine would be similar to the
decomposition of protonated dimethylalkylammonium
ions. Data are available to estimate the heat of the
following reaction, s-C4H9NH(CH3)2
 3 s-C4H9
 
NH(CH3)2, for which H
o(298) 330 kJ/mol. Loss of
NH3 from the amide-protonated species would be sim-
ilar to the decomposition of protonated propanamide,
C2H5CONH3
3 C2H5CO
  NH3, for which H
o(298)
 150 kJ/mol. Loss of water from the species proton-
ated on the hydroxyl group at C-6 would be similar to
the decomposition of protonated t-butyl alcohol,
t-C4H9OH2
3 t-C4H9
  H2O, for which H
o(298)  55
kJ/mol. For these competing cleavage reactions, one
may assume that activation energies for the decompo-
sitions are similar to the heats of reaction. Conse-
quently, the loss of water would be expected to be the
fastest decomposition process, by a very large margin.
Loss of ammonia from the protonated amide would be
the second most likely cleavage reaction.
In these experiments, there are multiple collisions
before the [M  H] ions are activated sufficiently to
decompose. Consequently, we may assume that a pro-
ton is transferred to the C-6 hydroxyl group in the
collisional activation process and that this ion then
rapidly decomposes with the loss of water. Similar
reasoning would explain the loss of ammonia.
The low energy CID spectra do not give sufficient
fragmentation for characterization of the tetracyclines.
However, as noted in Figure 3a, increasing the collision
energy greatly increases the extent of fragmentation.
Figure 5 shows CID spectra of the [M  H] ions from
oxytetracycline and the [M(D8)  D] analog of the
species produced by gas phase exchange using ND3.
These spectra were obtained with Ar as the collision gas
at collision energy of 25 eV, with corresponds to 2 eV
in the center of mass system.
Figure 5a shows spectra in the molecular weight
region from two sets of experiments on a single loop
injection of oxytetracycline using the API Sciex IIIplus
mass spectrometer. The protonated species and the 25
eV CID spectrum of [MH] at m/z 461 (Figure 5b) are
obtained using N2 as the nebulizer gas. Then ND3 is
introduced as the nebulizer gas for H/D exchange.
Although partially exchanged ions are observed, the
shift from m/z 461 to m/z 470 (Figure 5a) shows eight
exchangeable hydrogens in the molecule. The 25 eV
spectrum of the [M(D8)  D]
 ions at m/z 470 is also
obtained during this injection (Figure 5c). The correct
number of exchangeable hydrogens was detected from
similar experiments with all five of these tetracyclines.
A comparison of Figures 5b and c provides some
information about the product ions. The ions at m/z 443
or at 444 in Figure 5b correspond to loss of H2O or NH3
(or OH) from [M  H] at m/z 461. A single peak is
observed at m/z 450, corresponding to the loss of D2O
Table 2. Gas phase acidities of anions
Anion Compound name H°, kJ/mol G°, kJ/mol
Phenol 1461  1471 1432  1437
o-methyl phenol 1462  1465 1431  1434
p-dimethylaminophenol 1470  9 1441  8
3-methylpentanol 1556  12 1528  11
cyclohexanone 1543  18 1511  17
acetaldehyde 1533  12 1505  8
acetamide 1515  9 1485  8
Data from Ref. 45.
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and ND3 (not OD) from [M(D8)  D]
 at m/z 470. The
most abundant fragment ion, [MHH2ONH3]
 at
m/z 426 in Figure 5b, is predominantly [M(D8)  D 
D2O  ND3]
 at m/z 430 from the fully exchanged
species. The fragment ions from m/z 226 to 408 in Figure
5b contain three exchangeable hydrogens because the
m/z values are increased by three in Figure 5c. There is
a small amount of scrambling of exchangeable and
carbon bound hydrogens in the major decomposition
processes.
Additional experiments were done to analyze the
decomposition processes using multi-stage CID, MSN,
with an ion trap on [M  H] from oxytetracycline and
[M(D8)  D]
from oxytetracycline that had undergone
essentially complete H/D exchange in the liquid phase:
Ii(461)/Ii(470) in the ESI spectrum. As mentioned earlier
in this report, the CID of [M(D8)  D]
 showed water
loss as essentially the only product and 90% of this
loss was D2O (the other 10% loss was HDO at m/z
451). The CID spectrum of [M  H  H2O]
 at m/z 443
contains one major peak at m/z 426 and the CID
spectrum of the analogous deuterated species, [M(D8)
DD2O]
 at m/z 450, shows that this peak is90% loss
of ND3 at m/z 430 and 10% loss of HDO at m/z 431.
Scheme 1 shows a proposed mechanism for the loss of
H2O (D2O) followed by the loss of (NH3) ND3.
Table 3. Principal dissociation products of deprotonated tetracyclines
Product Ion m/z Deuterated product ion Deuterated m/z
tetracycline (MW  444, [M™H]  443, [M(d7)  D]  449)
443 - NHCO 400 449 - NDCO 405
443 - NH3 426 449 - ND3 429
426 - H2O 408 429 - D2O 409
426 - CO 398 429 - CO 401
426 - N(CH3)2 382 429 - N(CH3)2 385
382 - CO 354 385 - CO 357
426 - C3O2 358 429 - C3O2 361
358 - O¢C¢CH™N(CH3)2 273 361 - O¢C¢CH™N(CH3)2 276
oxytetracycline (MW  460, [M  H]  459, [M(d8)  D]  466)
459 - NHCO 416 466 - NDCO 422
459 - NH3 442 466 - ND3 446
442 - H2O 424 446 - D2O 426
442 - CO 414 446 - CO 418
442 - N(CH3)2 398 446 - N(CH3)2 402
398 - CO 370 402 - CO 374
442 - C3O2 374 446 - C3O2 378
374 - O¢C¢CH™N(CH3)2 289 378 - O¢C¢CH™N(CH3)2 293
chlorotetracycline (MW  478, [M  H]  477, [M(d7)  D]  483)
477 - NHCO 434 483 - NDCO 439
477 - NH3 460 483 - ND3 463
460 - H2O 442 463 - HDO 444
460 - CO 432 463 - CO 435
460 - N(CH3)2 416 463 - N(CH3)2 419
416 - CO 388 419 - CO 391
460 - C3O2 392 463 - C3O2 395
392 - O¢C¢CH™N(CH3)2 307 395 - O¢C¢CH™N(CH3)2 310
minocycline (MW  457, [M  H]  456, [M(d6)  D]  461)
456 - NHCO 413 461 - NDCO 417
456 - NH3 439 461 - ND3 441
439 - H2O 421 441 - HDO 422
439 - CO 411 441 - CO 413
439 - N(CH3)2 395 441 - N(CH3)2 397
395 - CO 367 397 - CO 369
439 - CO2 371 441 - C3O2 373
371 - O¢C¢CH™N(CH3)2 286 373 - O¢C¢CH™N(CH3)2 288
methacycline (MW  442, [M  H]  443, [M(d7)  D]  447)
441 - NHCO 398 447 - NDCO 403
441 - NH3 424 447 - ND3 427
424 - H2O 406 427 - HDO 408
424 - CO 396 427 - CO 399
396 - CO 368 399 - CO 371
424 - N(CH3)2 380 427 - N(CH3)2 383
380 - CO 352 383 - CO 355
352 - H2O 334 355 - HDO 336
424 - C3O2 356 427 - C3O2 359
356 - O¢C¢CH™N(CH3)2 271 359 - O¢C¢CH™N(CH3)2 274
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Figure 6 shows the more complex CID decompo-
sition pattern for the non-deuterated/deuterated
fragment ions at m/z 426 and 430. The 4263 408 
H2O decomposition for the non-deuterated species is
predominantly shifted to 430 3 411  HDO or to
430 3 410  D2O (minor pathway) for the deuter-
ated species. The 426 3 381  45 decomposition
for the non-deuterated species is shifted to 430 3
384  46 for the deuterated species. CID experi-
ments on the ions at m/z 408 (411, deuterated, Figure
7) show product ions at m/z 337 (339, 340), at m/z 365
(368), and minor ions at m/z 380 (382, 383) but not at
m/z 381 (384). Consequently, the ions at m/z 426 (430)
decompose by competing processes to give ions at
m/z 381 (384), at m/z 408 (411) and at m/z 408 (410).
Schemes 2 and 3 show proposed mechanisms for the
decomposition of the ions at m/z 426 (430) to give rise
to ion at m/z 381 (384) and ions at m/z 408 (411) and at
m/z 408 (410), respectively. The other high mass
fragment ions in those competitive processes can be
explained from losses of H2O, CO, and CH3NCH2.
The ions at m/z 226 contain three exchangeable
hydrogens, as indicated by the shift to m/z 229 in
Figure 6 for the deuterated species. The CID spectra
of ions at m/z 226 (229), data not shown, show
competing losses of CO and H2O (D2O) to form
product ions at m/z 198 (201) and at m/z 208 (209). The
ions at m/z 208 (209) decomposed by loss of CO.
Reasonable mechanisms for the formation of these
ions and subsequent decomposition reactions can be
proposed, but not strongly defended.
Table 1 shows the principal positive ion dissociation
products for these tetracyclines for the undeuterated
and deuterated species. These assignments were made
from MSN spectra on un-deuterated and deuterated
ions. The low mass fragment ions at m/z 58 (59), 98 (99),
126 (127), and 154 (155) all contain one exchangeable
hydrogen and probably originate from the A-ring of the
tetracyclines because they are observed for all five of
these compounds. The major decomposition paths are
similar for all of these compounds except that minocy-
cline and methacycline (without a tertiary OH at C-6)
do not lose water from [M  H].
Negative Ions
The tetracyclines can be analyzed as negative ions as
well as positive ions [40]. Figure 8 shows CID spectra
for the [M  H] ions from minocycline and the
[M(D6)  D]
 analog of the species produced by gas
phase exchange using ND3. Figure 8a shows spec-
trum obtained in the molecular weight region from
two sets of experiments during sample infusion of
minocycline using the API Sciex IIIplus mass spec-
trometer. The de-protonated species and the 20 eV
CID spectrum of [M  H] at m/z 456 (Figure 8b) are
obtained using N2 as the nebulizer gas. Then ND3 is
introduced as the nebulizer gas for H/D exchange.
Although partially exchanged ions are observed, the
shift from m/z 456 to m/z 461 (Figure 8a) shows six
exchangeable hydrogens in the molecule (the positive
ion spectra showed the expected increase of seven for
the exchanged species). The correct number of ex-
changeable hydrogens was detected in similar nega-
tive ion experiments with all five of the tetracyclines.
The 20 eV spectrum of the [M(D6)  D]
 ions at m/z
461 is also obtained after the introduction of ND3 as
the nebulizer gas (Figure 8c).
A comparison of Figures 8b and c provides some
information about the product ions. The ions at m/z
439 in Figure 8b correspond to loss of NH3 or OH
from [M  H] at m/z 456. The analogous peak for the
deuterated compound is observed in Figure 8c at m/z
441, corresponding to the loss of ND3 (not OD) from
[M(D6)  D]
 at m/z 461. The other high mass
fragment ions (m/z 286 –395) are shifted by two mass
units from Figure 8b to Figure 8c and contain two
exchangeable hydrogens. The fragment ion at m/z 180
in Figure 8b cannot come from decomposition of any
of these ions because it contains three exchangeable
hydrogens (shifted to m/z 183 in Figure 8c). The minor
ion at m/z 42 in Figure 8b has about the same relative
intensity in Figure 8c and is assigned to NCO.
Additional experiments were carried out to analyze
the decomposition processes using multi-stage CID,
MSN, with an ion trap on [M  H] ions from minocy-
cline and [M(D6)  D]
 ions from minocycline that had
undergone essentially complete H/D exchange in the
liquid phase. CID in the ion trap on [MH] at m/z 456
gave ions at m/z 439 and at 413 in about a 1/2 ratio. CID
in the ion trap on [M(D6)  D]
 at m/z 461 gave ions at
m/z 441 and 417 in the same ratio. Consequently, the
neutral molecules lost are NH3 (ND3) and HNCO
(DNCO). Ions at m/z 371 (373) in these CID spectra were
shown to result from decomposition of the ions at m/z
439 (441).
There are several possible sites of de-protonation in
minocycline whose relative acidities can be roughly
estimated from data on simple compounds. Table 2
shows gas phase acidities for anions of simple mole-
cules. These acidities represent heterolytic bond disso-
ciation energies, D(R  H): The larger D(R  H),
the stronger the anion is as a base and the weaker the
neutral compound is as an acid. The acidities are all
large and roughly similar. However, it is likely that the
dominant [M  H] ion is formed by removal of the
phenolic proton at C-10. In Table 2, the acidities of the
phenolic anions are 60–70 kJ/mol lower than the acid-
ities of the other oxygenated anions and about 45
kJ/mol lower than the acidity of the acetamide anion.
Using the difference in gas phase acidities of the anions,
(Go), to estimate the relative populations at the
different sites from the expression, exp(Go/RT),
one can estimate that species deprotonated at the phe-
nolic site is 1012 times as abundant as species depro-
tonated at any other hydroxyl site and 108 as abun-
dant as species deprotonated at the amide site. The
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ratios are not quantitatively correct, but do indicate
overwhelming deprotonation at the phenolic site.
Scheme 4 shows suggested mechanisms for the two
major decompositions from the de-protonated species.
There are no obvious simple cleavage reactions for the
[M  H] ions. We have no good way of estimating the
heats of these ionic rearrangement decompositions.
Intramolecular hydrogen bonding between the hy-
droxyl hydrogen at C-3 and the amide group is likely
and essential for the loss of ND3 from [M(D6)  D]

ions of minocycline. Although there may be electronic
effects transmitted through the four rings, we have
written the reactions as charge-remote decompositions
[45].
The CID mass spectra of the non-deuterated/deuter-
ated negative ions at m/z 439 (441) contain low abun-
dance ions at m/z 421 (422), corresponding to the loss of
H2O (HDO), a charge remote elimination of water,
perhaps from a 1,2-elimination between C-4a and
C-12a. Slightly larger abundances of product ions are
observed at m/z 411 (413), corresponding to the loss of
CO. More abundant product ions are observed at m/z
395 (397) by loss of dimethylamino radicals, (CH3)N
.
The most abundant product ions from dissociation of
ions at m/z 439 (441) are observed at m/z 371 (373).
Separate experiments show that the ions at m/z 371 (373)
are not formed from ions at m/z 395 and result from a
direct decomposition from ions at m/z 439 (441), corre-
sponding to a loss of C3O2.
The ions at m/z 395 (397) decompose to a small
extent to m/z 377 (378) from the loss of H2O (HDO),
perhaps from a 1,2-elimination between C-4a and
C-12a. Slightly more abundant product ions are ob-
served at m/z 367 (369) from loss of CO. The most
abundant product ions from CID of ions at m/z 395
(397) are ions at m/z 351 (353) from loss of the second
dimethylamino radical.
Table 3 shows the principal dissociation products of
five deprotonated tetracyclines. The decomposition
processes discussed above are observed for each spe-
cies. All of the tetracyclines gave ions corresponding to
[M–H–NH3–HNCO–C3O2–O¢C¢CH–NH(CH3)2]
 and
[M(D6)–ND3–DNCO–C3O2–O¢C¢CH–N(CH3)2]
. No
abundant products from loss of Cl or HCl were ob-
served from deprotonated chlortetracycline. We did not
scan low enough in mass to observed Cl as a product
ion.
Conclusions
Solution and gas phase H/D exchange allowed easy
determination of the number of replaceable hydrogens
in a series of tetracyclines in both negative and positive
ESI spectra. The CID spectra of the [M  H] ions were
Scheme 4. Proposed initial reactions and CID fragmentation pathways mechanisms showing the loss
of ammonia (NH3 and isocyanate (NHCO) from deprotonated minocycline and its fragment ions
determined from both H/D exchange patterns and ion trap MSN experiments. Numbers in parenthe-
ses refer to deuterated fragment ions.
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simpler than the CID spectra of the [M  H] ions, and
both gave structurally useful fragment ions. The CID
spectra of these tetracyclines can serve as models for the
identification of chemically or biologically modified
tetracyclines or related compounds. Single stage and
multiple stage CID experiments on the [M  H] and
[MH] ions and the fully exchanged analogs allowed
interpretation of some decomposition reactions. Very
similar decompositions were observed in positive ion
CID for all of the tetracyclines, and also in negative ion
CID for these compounds. Although the most basic site
in the tetracyclines is the dimethylamino group, the
dominant loss processes from [M  H] ions at low
collision energies are the losses of NH3 or of H2O (from
the species containing a tertiary HO-group at C-6).
These loss processes appear to be charge site decompo-
sitions involving replaceable hydrogens rather than
carbon-bound hydrogens. In the negative ion mode,
losses of ammonia and isocyanate appear to proceed
through charge-remote fragmentations.
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